Company page

Polaryx Therapeutics, Inc.

Polaryx Therapeutics, Inc. (ticker: PLYX) is a public company based in America, with a market capitalization of approximately $113.65 million. The company focuses on developing innovative therapies in the biotechnology sector. Investors can find more information about its operations and performance on its dedicated public company page.

PLYX:NASDAQUpdated August 14, 2026
Polaryx Therapeutics, Inc. logo
Ticker
PLYX:NASDAQ
Asset type
Stock
Market cap
$129.6M
Sector
Commercial Services
Industry
Miscellaneous Commercial Services
Exchange
NASDAQ
Currency
USD